Pfizer Inc.

Pharmaceuticals
United States
Executive 1Mr. Ian C. Read, MBA, Chairman; ; Chief Executive Officer | Chairman; ; Chief Executive Officer
Executive 2Mr. Frank A. D'Amelio, Executive Vice President; Chief Financial Officer | Director;
Earnings Per Share Growth (%)-55.49%
Cost of Goods Sold (US$ Millions)$9,577
Current Liabilities (US$ Millions)$21,631
Total Assets (US$ Millions)$57,702
Long Term Debt (Millions)$31,541
Return on Equity11.97%
Revenue (US$ Millions)$49,605
Total Company Assets$169,274
Revenue Growth (%)-3.84%
Net Income (US$ Millions)$9,135
Earnings Per Share (US$)$1.42
Total Equity (US$ Millions)$71,301
Profit Margin (%)18.42%
Debt To Equity Ratio (%)0.44%
Inventories (Millions)$5,663